60 Degrees Pharmaceuticals

SXTPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.080 M

$1.16 +11.54%

Close of 23 Sept 2026

Revenue

$1.01M

#3480 by revenue

Earnings

-$7.37M

Loss-making

Shares outstanding

3,516,988

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

60 Degrees Pharmaceuticals lists more than one class of stock. Company figures above cover all classes combined.

SXTPW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#469CapstoneCAPS$4.43M
#470Lakewood-Amedex BiotherapeuticsLABT$4.22M
#47160 Degrees PharmaceuticalsSXTP$4.08M
#472Artelo BiosciencesARTL$4.00M
#473OnconetixONCO$3.99M

What if 60 Degrees Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $29.8T

$8,486,503

Per share 7,315,950× higher

Bitcoin $1.69T

$481,696.39

Per share 415,256× higher

Nvidia $5.43T

$1,545,297

Per share 1,332,153× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for 60 Degrees Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.